Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,364.00
Bid: 12,398.00
Ask: 12,400.00
Change: 268.00 (2.22%)
Spread: 2.00 (0.016%)
Open: 12,150.00
High: 12,440.00
Low: 12,134.00
Prev. Close: 12,096.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks end shortened week on positive note

Thu, 06th Apr 2023 17:03

(Alliance News) - Stocks in London closed higher on Thursday, ahead of the long Easter weekend, defying gloomy local data as well as increasing expectations of a global economic slowdown.

The FTSE 100 index closed up 78.62 points, or 1.0% at 7,741.56 on Thursday. The FTSE 250 ended up 195.61 points, or 1.1%, at 18,797.03. The AIM All-Share closed up 7.51 points, or 0.9%, at 811.20.

The Cboe UK 100 ended up 1.1% at 774.27, the Cboe UK 250 closed up 1.5% at 16,382.65, and the Cboe Small Companies ended up 1.2% at 13,505.45.

UK house prices saw their weakest annual growth since late 2019, data from Halifax revealed.

According to the mortgage lender, average house prices edged up 0.8% in March on a monthly basis. Growth slowed from a 1.2% climb in February.

Annually, growth in house prices slowed to 1.6% in March, from the 2.1% climb seen in each of the previous three months. It was the weakest rate of growth since October 2019, Halifax noted.

In addition to this, growth in the UK construction sector slowed faster than expected last month, led by falling housing activity.

The S&P Global/CIPS UK construction purchasing managers' index fell to 50.7 points in March from 54.6 in February.

The slowdown was faster than the market had expected, with FXStreet-cited consensus anticipating a reading of 53.5.

As a result, sterling suffered. The pound was quoted at USD1.2436 at the London equities close on Thursday, down from USD1.2471 at the close on Wednesday.

Adding to Thursday's gloomy economic picture was the International Monetary Fund's managing director who warned that a continued slowdown in almost all the world's advanced economies is expected to drag global growth below 3% this year.

"With rising geopolitical tensions and still-high inflation, a robust recovery remains elusive," Kristalina Georgieva said in prepared remarks ahead of the IMF and World Bank's spring meetings next week.

She added that world growth will likely remain at roughly three percent for the next half-decade, the lowest medium-term forecast since the 1990s.

In the FTSE 100, Shell rose 2.3% after it said it expects a rise in Integrated Gas production in the first quarter of 2023.

However, the oil major also predicted an adjusted loss in its corporate segment between USD900 million and USD1.2 billion, widening from USD600 million in the fourth quarter of 2022. The outcome "includes one-off tax charges", the company said.

Oil company profits have come under tax scrutiny recently. Energy firms have benefitted from robust oil prices, a stark contrast to a cost of living crisis consumers are suffering from.

For Integrated Gas, Shell forecast production between 930,000 to 970,000 barrels of oil equivalent, up from 917,000 boe in the fourth quarter.

AstraZeneca climbed 0.8% after the NHS approved the use of its drug Olaparib, also known as Lynparza, for patients with breast cancer and prostate cancer.

The drug targets cancers with BRCA 1 or BRCA 2 mutations and works by stopping cancer cells from being able to repair their DNA, which causes the cancerous cells to die.

In the FTSE 250, Tui jumped 12% as it reported that booking momentum remained encouraging ahead of the Easter holding.

The holiday operator said bookings and trends for Easter holidays confirmed strong demand across all markets for destinations such as the Canary Islands, Turkey, the Balearics, mainland Spain, Egypt and Greece.

It expects over 500,000 customers on holiday with Tui over Easter, with a load factor in the range of 95%, which it said was broadly in line pre-pandemic levels.

Ferrexpo added 5.4% as it announced that iron ore pellet production doubled quarter-on-quarter in the first three months of 2023, as it saw a more steady supply of electricity during the period.

The firm, with operations in central Ukraine, reported that production for the first quarter ended March 31 was 901,000 tonnes, compared with 420,000 million tonnes in the fourth quarter of 2022.

Elsewhere in London, Robert Walters fell 2.5% as the company reported a "slower" start to the year amid continued economic uncertainty.

The recruitment company said net fee income in the first quarter of 2023 was GBP102.4 million, up 4.1% from GBP98.4 million the year prior.

Liberum analyst Sanjay Vidyarthi said that the first quarter slowdown was "as expected", warning that the first half of the year will "likely to be difficult" for the firm.

In European equities on Thursday, the CAC 40 in Paris ended up 0.1%, while the DAX 40 in Frankfurt ended 0.5% higher.

The euro stood at USD1.0919 at the European equities close on Thursday, unchanged from USD1.0919 at the same time on Wednesday.

Against the yen, the dollar was trading at JPY131.72, higher compared to JPY130.94 late Wednesday.

Stocks in New York were in the red at the London equities close, with the Dow Jones Industrial Average down 0.3%, the S&P 500 index down 0.2%, and the Nasdaq Composite trading marginally lower.

US initial claims for unemployment support topped expectations last week, in a further sign that the once red-hot labour market is weakening.

According to the Department of Labor, initial jobless claims amounted to 228,000 for the week ended April 1, down 18,000 from a week earlier. The previous week's reading was upwardly revised to 246,000 from 198,000.

The latest figure came in above expectations of 200,000.

The labour market data comes ahead of a "pivotal" nonfarm payrolls reading, released on Friday at 1330 BST.

Axel Rudolph, senior market analyst at IG, said: "Friday's US payrolls report will be a pivotal one for stocks. The worst outcome would be rising wages and a weaker jobs number, something that might reverse the growing expectation of a Fed pause in May. Such a scenario would likely put stocks at risk of giving back their recent gains."

Brent oil was quoted at USD84.88 a barrel at the London equities close on Thursday, up from USD84.48 late Wednesday. Gold was quoted at USD2,009.21 an ounce, lower against USD2,021.30.

"The outlook for gold is closely tied to that of US yields which have fallen considerably in the aftermath of the banking turmoil and are falling once more as recession fears resurface. That's helped propel gold above USD2,000, a level above which it has only ever spent a handful of days," said Craig Erlam, senior market analyst at Oanda.

Financial markets in London, New York and across Europe and will be closed tomorrow for Good Friday. In Friday's economic calendar, the latest US nonfarm payrolls reading is reported at 1330 BST.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.